Growth Metrics

Varex Imaging (VREX) Cash & Equivalents (2016 - 2026)

Varex Imaging (VREX) has disclosed Cash & Equivalents for 11 consecutive years, with $119.5 million as the latest value for Q1 2026.

  • Quarterly Cash & Equivalents fell 32.1% to $119.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $119.5 million through Jan 2026, down 32.1% year-over-year, with the annual reading at $145.0 million for FY2025, 14.05% down from the prior year.
  • Cash & Equivalents for Q1 2026 was $119.5 million at Varex Imaging, down from $145.0 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $205.1 million in Q2 2025, with the low at $81.5 million in Q4 2022.
  • Average Cash & Equivalents over 5 years is $134.5 million, with a median of $138.8 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents tumbled 48.35% in 2022, then soared 73.37% in 2023.
  • Over 5 years, Cash & Equivalents stood at $81.5 million in 2022, then skyrocketed by 73.37% to $141.3 million in 2023, then rose by 19.39% to $168.7 million in 2024, then fell by 14.05% to $145.0 million in 2025, then dropped by 17.59% to $119.5 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $119.5 million, $145.0 million, and $136.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.